140 related articles for article (PubMed ID: 10486467)
1. Inhibition of human endometrial cancer cell growth in vitro and in vivo by somatostatin analog RC-160.
Mishima M; Yano T; Jimbo H; Yano N; Morita Y; Yoshikawa H; Schally AV; Taketani Y
Am J Obstet Gynecol; 1999 Sep; 181(3):583-90. PubMed ID: 10486467
[TBL] [Abstract][Full Text] [Related]
2. Antagonists of growth hormone-releasing hormone and somatostatin analog RC-160 inhibit the growth of the OV-1063 human epithelial ovarian cancer cell line xenografted into nude mice.
Chatzistamou I; Schally AV; Varga JL; Groot K; Armatis P; Busto R; Halmos G
J Clin Endocrinol Metab; 2001 May; 86(5):2144-52. PubMed ID: 11344219
[TBL] [Abstract][Full Text] [Related]
3. Somatostatin analog RC-160 inhibits the growth of human osteosarcomas in nude mice.
Pinski J; Schally AV; Halmos G; Szepeshazi K; Groot K
Int J Cancer; 1996 Mar; 65(6):870-4. PubMed ID: 8631606
[TBL] [Abstract][Full Text] [Related]
4. Inhibitory effects of somatostatin analogue RC-160 and bombesin/gastrin-releasing peptide antagonist RC-3095 on the growth of the androgen-independent Dunning R-3327-AT-1 rat prostate cancer.
Pinski J; Reile H; Halmos G; Groot K; Schally AV
Cancer Res; 1994 Jan; 54(1):169-74. PubMed ID: 7903203
[TBL] [Abstract][Full Text] [Related]
5. [Telomerase antisense inhibition and chemotherapeutic combination treatments for the proliferation of endometrial cancer in vitro and in vivo].
Chen XJ; Zheng W; Chen LL; Chen ZB; Wang SQ
Zhonghua Yi Xue Za Zhi; 2004 Oct; 84(20):1721-5. PubMed ID: 15569435
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of growth of MKN45 human gastric-carcinoma xenografts in nude mice by treatment with bombesin/gastrin-releasing-peptide antagonist (RC-3095) and somatostatin analogue RC-160.
Pinski J; Halmos G; Yano T; Szepeshazi K; Qin Y; Ertl T; Schally AV
Int J Cancer; 1994 May; 57(4):574-80. PubMed ID: 7910153
[TBL] [Abstract][Full Text] [Related]
7. Effect of somatostatin analog RC-160 and bombesin/gastrin releasing peptide antagonist RC-3095 on growth of PC-3 human prostate-cancer xenografts in nude mice.
Pinski J; Schally AV; Halmos G; Szepeshazi K
Int J Cancer; 1993 Dec; 55(6):963-7. PubMed ID: 7902829
[TBL] [Abstract][Full Text] [Related]
8. Targeted therapy with a cytotoxic somatostatin analog, AN-238, inhibits growth of human experimental endometrial carcinomas expressing multidrug resistance protein MDR-1.
Engel JB; Schally AV; Halmos G; Baker B; Nagy A; Keller G
Cancer; 2005 Sep; 104(6):1312-21. PubMed ID: 16047355
[TBL] [Abstract][Full Text] [Related]
9. Effects of somatostatin analogue RC-160 and bombesin/gastrin-releasing peptide antagonists on the growth of human small-cell and non-small-cell lung carcinomas in nude mice.
Pinski J; Schally AV; Halmos G; Szepeshazi K; Groot K; O'Byrne K; Cai RZ
Br J Cancer; 1994 Nov; 70(5):886-92. PubMed ID: 7947094
[TBL] [Abstract][Full Text] [Related]
10. Effect of the molecular targeted drug, erlotinib, against endometrial cancer expressing high levels of epidermal growth factor receptor.
Nishimura T; Nakamura K; Yamashita S; Ikeda S; Kigure K; Minegishi T
BMC Cancer; 2015 Dec; 15():957. PubMed ID: 26673416
[TBL] [Abstract][Full Text] [Related]
11. Somatostatin analogues and bombesin/gastrin-releasing peptide antagonist RC-3095 inhibit the growth of human glioblastomas in vitro and in vivo.
Pinski J; Schally AV; Halmos G; Szepeshazi K; Groot K
Cancer Res; 1994 Nov; 54(22):5895-901. PubMed ID: 7954420
[TBL] [Abstract][Full Text] [Related]
12. Inhibitory effects of antagonists of bombesin/gastrin releasing peptide (GRP) and somatostatin analog (RC-160) on growth of HT-29 human colon cancers in nude mice.
Radulovic S; Schally AV; Reile H; Halmos G; Szepeshazi K; Groot K; Milovanovic S; Miller G; Yano T
Acta Oncol; 1994; 33(6):693-701. PubMed ID: 7946450
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of human epithelial ovarian cancer cell growth in vitro by somatostatin analog RC-160.
Yano T; Radulovic S; Osuga Y; Kugu K; Yoshikawa H; Taketani Y; Schally AV
Oncology; 2000; 59 Suppl 1():45-9. PubMed ID: 11096356
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of proliferation of PC-3 human prostate cancer by antagonists of growth hormone-releasing hormone: lack of correlation with the levels of serum IGF-I and expression of tumoral IGF-II and vascular endothelial growth factor.
Plonowski A; Schally AV; Letsch M; Krupa M; Hebert F; Busto R; Groot K; Varga JL
Prostate; 2002 Aug; 52(3):173-82. PubMed ID: 12111694
[TBL] [Abstract][Full Text] [Related]
15. Expression of the somatostatin receptor subtype-2 gene predicts response of human pancreatic cancer to octreotide.
Fisher WE; Muscarella P; O'Dorisio TM; O'Dorisio MS; Kim JA; Doran TA; Sabourin CL; Schirmer WJ
Surgery; 1996 Aug; 120(2):234-40; discussion 240-1. PubMed ID: 8751588
[TBL] [Abstract][Full Text] [Related]
16. Antiproliferative effects of the somatostatin analogue octreotide (SMS 201-995) on ZR-75-1 human breast cancer cells in vivo and in vitro.
Weckbecker G; Liu R; Tolcsvai L; Bruns C
Cancer Res; 1992 Sep; 52(18):4973-8. PubMed ID: 1325289
[TBL] [Abstract][Full Text] [Related]
17. Somatostatin analog RC-160 inhibits growth of CFPAC-1 human pancreatic cancer cells in vitro and intracellular production of cyclic adenosine monophosphate.
Qin Y; Ertl T; Groot K; Horvath J; Cai RZ; Schally AV
Int J Cancer; 1995 Mar; 60(5):694-700. PubMed ID: 7860145
[TBL] [Abstract][Full Text] [Related]
18. Antiproliferative signaling of luteinizing hormone-releasing hormone in human endometrial and ovarian cancer cells through G protein alpha(I)-mediated activation of phosphotyrosine phosphatase.
Gründker C; Völker P; Emons G
Endocrinology; 2001 Jun; 142(6):2369-80. PubMed ID: 11356684
[TBL] [Abstract][Full Text] [Related]
19. Antitumor effects of the cytotoxic luteinizing hormone-releasing hormone analog AN-152 on human endometrial and ovarian cancers xenografted into nude mice.
Gründker C; Völker P; Griesinger F; Ramaswamy A; Nagy A; Schally AV; Emons G
Am J Obstet Gynecol; 2002 Sep; 187(3):528-37. PubMed ID: 12237622
[TBL] [Abstract][Full Text] [Related]
20. Effect of gastrointestinal hormones and synthetic analogues on the growth of pancreatic cancer.
Robertson JF; Watson SA; Hardcastle JD
Int J Cancer; 1995 Sep; 63(1):69-75. PubMed ID: 7558455
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
